GAOMA Therapeutics’ approach is to develop molecules able to impact on mechanisms underlying epilepsy and its comorbid disorders. Among these mechanisms, neuroinflammation and aberrant brain plasticity are more particularly targeted by GAOMA.
Thanks to this upstream approach, the objective is to address different symptoms of epilepsy, to potentially modify the disease, with well tolerated treatments.
The drug candidates developed by GAOMA are lipid derivatives with various pharmacological properties. Based on their mechanism of action, GAOMA will also explore the interest of these molecules for the treatment of different neurological and inflammatory disorders.